Ibrance 75 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26FT2NM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,123
Award facts
- Contract value 100% obligated
- $17,122.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,122.82 to AmerisourceBergen Drug Corp for the supply of IBRANCE 75 mg tablets (quantity: 7 units) with a completion date of February 10, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award leverages AmerisourceBergen's parent company, Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. This prime IDC serves as the overarching vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs and maintains an extensive portfolio of pharmaceutical deliveries through the DLA Medical Supply Chain. The company's demonstrated capability to fulfill federal requirements through open competition is evidenced by its consistent delivery of diverse pharmaceutical products across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. This delivery order for IBRANCE, a specialized oncology medication, exemplifies the company's role in supporting the Department of Defense's medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26FT2NM?
SPE2DR26FT2NM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FT2NM worth?
The government has obligated $17,123 on SPE2DR26FT2NM.
Is contract SPE2DR26FT2NM an order under another contract?
Yes. SPE2DR26FT2NM is a delivery order under SPE2DR25D3109, an indefinite delivery contract.
Was contract SPE2DR26FT2NM competed?
The extent of competition for SPE2DR26FT2NM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award